Highlights in Hepatocellular Carcinoma From the 2021 European Society for Medical Oncology Congress

IMbrave150: Exploratory Efficacy and Safety Results in Patients With Hepatocellular Carcinoma Without Macrovascular Invasion or Extrahepatic Spread Treated With Atezolizumab + Bevacizumab or Sorafenib The global, […]